1,117 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Purchased by TD Private Client Wealth LLC

TD Private Client Wealth LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,117 shares of the company’s stock, valued at approximately $148,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Whittier Trust Co. of Nevada Inc. purchased a new stake in shares of Astera Labs in the 4th quarter worth approximately $25,000. Steward Partners Investment Advisory LLC boosted its holdings in Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after acquiring an additional 99 shares in the last quarter. Kestra Investment Management LLC purchased a new stake in shares of Astera Labs in the fourth quarter worth $28,000. Geneos Wealth Management Inc. purchased a new stake in shares of Astera Labs in the fourth quarter worth $36,000. Finally, Global Retirement Partners LLC increased its holdings in shares of Astera Labs by 3,155.6% during the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after acquiring an additional 284 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

ALAB stock opened at $72.19 on Wednesday. The business’s 50-day moving average is $89.05 and its two-hundred day moving average is $90.03. The company has a market cap of $11.71 billion and a price-to-earnings ratio of -41.73. Astera Labs, Inc. has a fifty-two week low of $36.22 and a fifty-two week high of $147.39.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. Equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In related news, General Counsel Philip Mazzara sold 7,536 shares of the firm’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total value of $693,839.52. Following the transaction, the general counsel now directly owns 241,209 shares of the company’s stock, valued at approximately $22,208,112.63. This trade represents a 3.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael E. Hurlston sold 2,500 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $92.08, for a total value of $230,200.00. Following the sale, the director now directly owns 91,794 shares of the company’s stock, valued at $8,452,391.52. This represents a 2.65 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 570,990 shares of company stock worth $50,242,702 in the last 90 days.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ALAB. Stifel Nicolaus increased their price objective on shares of Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Needham & Company LLC reiterated a “buy” rating and set a $140.00 price target on shares of Astera Labs in a report on Tuesday, February 11th. Raymond James initiated coverage on shares of Astera Labs in a report on Friday, March 14th. They issued an “outperform” rating and a $82.00 price objective for the company. Barclays increased their target price on Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. Finally, Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a research note on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Astera Labs has an average rating of “Buy” and a consensus target price of $112.77.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.